Peter C. Taylor
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial.
Journal: Annals of the rheumatic diseases
Published: August 24, 2011
Patient perceptions concerning pain management in the treatment of rheumatoid arthritis.
Journal: The Journal of international medical research
Published: October 08, 2010
The importance of the patients' experience of RA compared with clinical measures of disease activity.
Journal: Clinical and experimental rheumatology
Published: February 09, 2010
Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases.
Journal: Current opinion in pharmacology
Published: January 04, 2010
Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.
Journal: Nature reviews. Rheumatology
Published: October 03, 2009
How do the efficacy and safety of abatacept and infliximab compare in the treatment of active RA?
Journal: Nature clinical practice. Rheumatology
Published: November 19, 2008
MRI-detected bone marrow edema in early rheumatoid arthritis.
Journal: Nature clinical practice. Rheumatology
Published: May 27, 2008
Rituximab in the treatment of rheumatoid arthritis.
Journal: Expert review of clinical immunology
Published: January 01, 2007
Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis.
Journal: Arthritis and rheumatism
Published: December 31, 2005
Is abatacept an effective treatment for patients with RA who do not respond to other anti-TNF treatments?
Journal: Nature clinical practice. Rheumatology
Published: December 01, 2005
Tumour necrosis factor alpha as a therapeutic target for immune-mediated inflammatory diseases.
Journal: Current opinion in biotechnology
Published: November 25, 2004
Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis.
Journal: Arthritis and rheumatism
Published: April 13, 2004
Last Updated: 09/26/2026